🇺🇸 FDA
Patent

US 11027071

Intradermal jet injection electroporation device

granted A61KA61K9/0021

Quick answer

US patent 11027071 (Intradermal jet injection electroporation device) held by Inovio Pharmaceuticals, Inc. expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Inovio Pharmaceuticals, Inc.
Grant date
Tue Jun 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K9/0021